Nationwide Small Company Growth Fund Institutional Service Class (NWSIX)

18.12
Net Asset Value
+0.44%
1 Day
+4.44%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.21%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation; current income is a secondary consideration in selecting portfolio investments. The fund normally invests at least 80% of its net assets in common stocks of small-cap companies. It employs a "growth" style of investing. In other words- the fund subadviser seeks companies whose earnings are expected to grow consistently faster than those of other companies. In pursuing this approach- the subadviser seeks to build a portfolio of exceptional small companies- purchased early in their corporate life cycle- that have the wherewithal to become exceptional large companies.

Performance

1 month+0.55% 3 years+16.27%
3 months+5.02% 5 years+16.21%
1 year+27.68% Since inception+18.38%
Data through --

Peer Comparisonvs. Small growth

 NWSIXCategory
Performance 5-yr return+16.21%+13.96%
Expense ratio1.21%1.28%
Risk 5 year sharpe ratio1.210.98
Net assets$261.0M$1.1B
Average market cap$3.6B$4.0B
Average P/E51.732.3
Portfolio turnover16%16%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyNationwide
Fund manager & tenureRobert Hall / 6 Years
Minimal initial investment$50,000.00
Minimum IRA investment--

Holdings

U.S. stock95.59%
Cash4.40%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
TYL Tyler Technologies Inc4.91%
MANH Manhattan Associates Inc4.80%
PRLB Proto Labs Inc4.71%
PAYC Paycom Software Inc4.58%
CMD Cantel Medical Corp4.43%
VEEV Veeva Systems Inc4.40%
BLKB Blackbaud Inc4.31%
NEOG Neogen Corp4.13%
CGNX Cognex Corp4.03%
ABMD Abiomed Inc3.99%